MRAS gene marker rs9818870 is not associated with acute coronary syndrome in the Czech population and does not predict mortality in males after acute coronary syndrome
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F17%3A00076221" target="_blank" >RIV/00023001:_____/17:00076221 - isvavai.cz</a>
Alternative codes found
RIV/00064165:_____/17:10366594
Result on the web
<a href="http://www.advances.am.wroc.pl/pdf/2017/26/8/1213.pdf" target="_blank" >http://www.advances.am.wroc.pl/pdf/2017/26/8/1213.pdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.17219/acem/67460" target="_blank" >10.17219/acem/67460</a>
Alternative languages
Result language
angličtina
Original language name
MRAS gene marker rs9818870 is not associated with acute coronary syndrome in the Czech population and does not predict mortality in males after acute coronary syndrome
Original language description
Background. Genome-wide association studies (GWAs) focused on cardiovascular diseases reveal variants within genes which have not been analyzed through the pre-GWAs era, and whose function is often unknown. One of them is variant rs9818870 at the MRAS gene locus. Objectives. To analyze if MRAS polymorphism is associated with acute coronary syndrome (ACS) risk in a Czech population and with mortality in male patients after myocardial infarction. Material and methods. 1,779 male patients with ACS (aged 55.3 +/- 7.9 years) and 673 female patients with ACS (aged 64.0 +/- 8.1 years) were genotyped for rs9818870 polymorphism using the PCR-RFLP method. In a subset of 1,221 patients, detailed diagnoses (901 subjects with STEMI, 280 subjects with NSTEMI, 40 cases with unstable angina pectoris) were recorded. In 1,614 males, records about total and cardiovascular mortality were available. Results. Whether the entire populations or males and females have been analyzed separately or not, we have not confirmed the described association between DNA marker rs9818870 and ACS in Czechs (30.4% vs 29.4% carriers of the minor T allele [ recessive model], p = 0.54; OR 1.05; 95% CI 0.89-1.24 for males and 32.1% vs 29.7% carriers of the minor T allele, p = 0.28; OR 1.12; 95% CI 0.91-1.37 for females). Types of the ACS (STEMI and NSTEMI) or mortality (in males only) were not associated with the analyzed polymorphism (all p > 0.34). Conclusions. The rs9818870 variant is not associated with ACS or mortality in ACS patients in the Czech Slavonic population.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
<a href="/en/project/NT12217" target="_blank" >NT12217: Genetic factors determining the risk of atherothrombotic vascular events in patients without classical risk factors of atherosclerosis and in patients treated with a statin.</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Advances in clinical and experimental medicine
ISSN
1899-5276
e-ISSN
—
Volume of the periodical
26
Issue of the periodical within the volume
8
Country of publishing house
PL - POLAND
Number of pages
5
Pages from-to
1213-1217
UT code for WoS article
000418449900006
EID of the result in the Scopus database
—